相关实验视频
Updated: Aug 15, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
与深度大脑刺激相比,用药物对STNβ-波段活动的矛盾调节与药物相比
Meghan E Hill1, Luke A Johnson1, Jing Wang1
1Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
这种帕金森病 (PD) 病例显示出异常的大脑活动. 矛盾的是,随着药物治疗,亚thalamic核β带振荡增加,但随着深度大脑刺激 (DBS) 减少,尽管症状有所改善.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 运动障碍 运动障碍
背景情况:
- 脑下细胞核 (STN) 的β频段振荡 (13-35 Hz) 是帕金森病 (PD) 的关键生物标志物.
- 这些振荡对于描述疾病状态和开发自适应性深度大脑刺激 (DBS) 系统至关重要.
研究的目的:
- 报告一个独特的患者在STNβ频段振荡中表现出异常的治疗响应调制.
- 为了研究药物,DBS和贝塔带活性在PD中的复杂关系.
主要方法:
- 使用外部化DBS引线检查STN本地场潜力 (LFPs).
- 在四个条件下评估PD运动症状:关闭药物,开启药物 (MEDS),DBS ON和MEDS+DBS.
主要成果:
- 该患者在服用莱沃多巴和普拉米佩克索尔 (MEDS) 的情况下,表现出beta功率的悖论性增加.
- 在DBS和MEDS+DBS期间β功率减弱,尽管在所有治疗条件下显著的运动改善 (>50%).
- 这表明β振荡对治疗的复杂,不均的反应.
结论:
- 这一案例强调了进一步研究贝塔振荡在PD病理生理学中的作用的需要.
- 强调了个性化方法在开发基于生物标记的闭环DBS算法的重要性.
更多相关视频
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
相关概念视频
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Neurochemical Transmission: Sites of Drug Action
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drugs Affecting Neurotransmitter Release or Uptake